MarketBeat cites USD 2.30 target for Cronos Group stock
Published on 10/20/2026 at 21:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and reporting date
- MarketBeat reported a five-brokerage consensus target of USD 2.30 on October 7, 2026.
- Second-quarter revenue reached USD 53.01 million, up 58.00 percent year over year.
- Cronos Group stock costs EUR 2.92 at Lang & Schwarz on October 20, 2026 at 9:47 p.m. CEST.
- Cronos Group scheduled its third-quarter earnings call for November 5, 2026.
Cronos Group (ISIN CA22717L1013) is trading at EUR 2.92 at Lang & Schwarz on October 20, 2026 at 9:47 p.m. CEST. A five-brokerage consensus cited by MarketBeat on October 7, 2026 put the average 12-month target at USD 2.30.
Revenue growth remains central
Cronos reported second-quarter 2026 revenue of USD 53.01 million, an increase of 58.00 percent from the same period a year earlier. The figure exceeded the USD 44.20 million consensus cited by MarketBeat, while adjusted earnings per share reached USD 0.09 against a USD 0.01 expectation.
The Globe and Mail reported that gross profit rose to USD 28.50 million in the second quarter, while gross margin expanded to 54.00 percent from 43.00 percent a year earlier. International revenue outside Israel increased 88.00 percent, led by demand in Germany.
Nasdaq price stays below its high
On the Nasdaq, Cronos last traded at USD 3.30 on October 20, 2026 at 3:55 p.m. ET, up 1.39 percent from USD 3.25. The USD 3.30 price stood 8.59 percent below the 52-week high of USD 3.61 and 44.74 percent above the 52-week low of USD 2.28.
The current Nasdaq valuation was USD 1.2 billion, with a price-to-earnings ratio of 17.51. The USD 2.30 consensus target is 30.30 percent below the Nasdaq price of USD 3.30, giving the target a different perspective from the euro quotation.
November 5 earnings date
Cronos lists its third-quarter 2026 earnings conference call for November 5, 2026, at 8:30 a.m. ET on its investor-relations page. The scheduled date gives the next concrete checkpoint for revenue, margins and the integration of the company's European expansion.
Comparison with peers
Cronos Group: up 1.39 percent on Nasdaq, P/E 17.51, market capitalization USD 1.2 billion.
Canopy Growth Corporation: up 0.85 percent on Nasdaq, P/E minus 1.51, market capitalization USD 305.3 million.
Tilray Brands: up 0.90 percent on Nasdaq, P/E minus 2.19, market capitalization USD 341.9 million.
Euro quote after hours
The euro quotation places Cronos at EUR 2.92 at Lang & Schwarz on October 20, 2026 at 9:47 p.m. CEST. The Nasdaq price and the consensus target remain the more direct dollar benchmarks for assessing the stock's valuation.
The further course of trading is shown by the continuously updated real-time quote of Cronos Group stock.
Cronos Group market snapshot
- Company: Cronos Group Inc.
- ISIN: CA22717L1013
- Ticker: CRON
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 20, 2026, 9:47 p.m. CEST): EUR 2.92
- Market capitalization: USD 1.2 billion (as of October 20, 2026)
- 52-week range: USD 2.28-3.61 (as of October 20, 2026)
- Sector / Industry: Healthcare / Drug Manufacturers - Specialty & Generic
- Next earnings date: November 5, 2026
Market context: Market report S&P 500.
